The enantioselective total synthesis of (+)-clusianone

Chemical Communications

Volumn 51, Issue 12, 2015, Pages 2259-2261

  Horeischi, Fiene ^a   Guttroff, Claudia ^a   Plietker, Bernd ^a  

^a UNIVERSITY OF STUTTGART   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLACETONE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; CLUSIANONE; NATURAL PRODUCT; UNCLASSIFIED DRUG; 7-EPICLUSIANONE; ANTINEOPLASTIC AGENT; BENZOPHENONE DERIVATIVE; BENZOQUINONE DERIVATIVE; RUTHENIUM;

ALLYLATION; ARTICLE; CATALYSIS; CATALYST; CLAISEN CONDENSATION; DECARBOXYLATION; DIASTEREOISOMER; DRUG SYNTHESIS; ENANTIOSELECTIVITY; EPSTEIN BARR VIRUS; HUMAN IMMUNODEFICIENCY VIRUS; NONHUMAN; OPTICAL ROTATION; RING CLOSING METATHESIS; CHEMISTRY; CONFORMATION; STEREOISOMERISM; SYNTHESIS; X RAY CRYSTALLOGRAPHY;

ANTI-HIV AGENTS; ANTINEOPLASTIC AGENTS; BENZOPHENONES; BENZOQUINONES; CATALYSIS; CRYSTALLOGRAPHY, X-RAY; MOLECULAR CONFORMATION; RUTHENIUM; STEREOISOMERISM;

EID: 84921836085     PISSN: 13597345     EISSN: 1364548X     Source Type: Journal    
DOI: 10.1039/c4cc09701g     Document Type: Article

References (40)

1. R. Ciochina and R. B. Grossman, Chem. Rev., 2006, 106, 3963.
2. (a) J.-A. Richard, R. H. Pouwer and D. Y.-K. Chen, Angew. Chem., Int. Ed., 2012, 51, 4536;
3. (b) J. T. Njardarson, Tetrahedron, 2011, 67, 7631.
4. (a) I. P Singh and S. B. Bharate, Nat. Prod. Rep., 2006, 23, 558;
5. (b) I. P. Singh, J. Sidana, S. B. Bharate and W. Foley, Nat. Prod. Rep., 2010, 27, 393.
6. J. H. George, M. D. Hesse, J. E. Baldwin and R. M. Adlington, Org. Lett., 2010, 12, 3532.
7. (a) N. Biber, K. Möws and B. Plietker, Nat. Chem., 2011, 3, 938;
8. (b) K. Lindermayr and B. Plietker, Angew. Chem., Int. Ed., 2013, 52, 12183;
9. (c) F. Horeischi, N. Biber and B. Plietker, J. Am. Chem. Soc., 2014, 136, 4026;
10. (d) Q. Zhang and J. A. Porco Jr., Org. Lett., 2012, 14, 1796;
11. (e) Q. Zhang, B. Mitasev, J. Qi and J. A. Jr. Porco, J. Am. Chem. Soc., 2010, 132, 14212.
12. (a) S. J. Spessard and B. M. Stoltz, Org. Lett., 2002, 4, 1943;
13. (b) T. Pouplin, B. Tolon, P. Nuhant, B. Delpech and C. Marazano, Eur. J. Org. Chem., 2007, 5117;
14. (c) G. Mehta, T. Dhanbal and M. K. Bera, Tetrahedron Lett., 2010, 51, 5302;
15. (d) V. Rodeschini, N. M Ahmad and N. S. Simpkins, Org. Lett., 2006, 8, 5283;
16. (e) N. M. Ahmad, V. Rodeschini, N. S. Simpkins, S. E. Ward and A. J. Blake, J. Org. Chem., 2007, 72, 4803;
17. (f) P. Nuhant, M. David, T. Pouplin, B. Delpech and C. Marazano, Org. Lett., 2007, 9, 287.
18. (a) H. Usuda, M. Kanai and M. Shibasaki, Org. Lett., 2002, 4, 859;
19. (b) H. Usuda, M. Kanai and M. Shibasaki, Tetrahedron Lett., 2002, 43, 3621;
20. (c) Y. Shimizu, A. Kuramochi, H. Usuda, M. Kanai and M. Shibasaki, Tetrahedron Lett., 2007, 48, 4173;
21. (d) A. Kuramochi, H. Usuda, K. Yamatsugu, M. Kanai and M. Shibasaki, J. Am. Chem. Soc., 2005, 127, 14200.
22. (a) C. Tsukano, D. R. Siegel and S. J. Danishefsky, Angew. Chem., Int. Ed., 2007, 46, 8840;
23. (b) D. R. Siegel and S. J. Danishefsky, J. Am. Chem. Soc., 2006, 128, 1048.
24. (a) J. Qi and J. A. Jr. Porco, J. Am. Chem. Soc., 2007, 129, 12682;
25. (b) B. Mitasev and J. A. Porco Jr., Org. Lett., 2009, 11, 2285;
26. (c) M. Uwamori and M. Nakada, Nat. Prod. Commun., 2013, 8, 955.
27. G. Bellavance and L. Barriault, Angew. Chem., Int. Ed., 2014, 53, 6701.
28. (a) M. R. Garnsey, D. Lim, J. M. Yost and D. M. Coltart, Org. Lett., 2010, 12, 5234;
29. (b) M. R. Garnsey, J. A. Matous, J. J. Kwiek and M. D. Coltart, Bioorg. Med. Chem. Lett., 2011, 21, 2406.
30. J. H. Boyce and J. A. Jr. Porco, Angew. Chem., Int. Ed., 2014, 53, 7832.
31. V. Rodeschini, N. S. Simpkins and C. Wilson, J. Org. Chem., 2007, 72, 4265.
32. (a) J. Qi, A. B. Beeler, Q. Zhang and J. A. Jr. Porco, J. Am. Chem. Soc., 2010, 132, 13642;
33. (b) Y. Shimizu, S. L. Shi, H. Usuda, M. Kanai and M. Shibasaki, Angew. Chem., Int. Ed., 2010, 49, 1103;
34. (c) B. A. Sparling, D. C. Moebius and M. D. Shair, J. Am. Chem. Soc., 2013, 135, 644.
35. J. A. Keith, D. C. Behenna, N. Sherden, J. T. Mohr, S. Ma, S. C. Marinescu, R. J. Nielsen, J. Oxgaard, B. M. Stoltz and W. A. Goddard, J. Am. Chem. Soc., 2012, 134, 19050.
36. (a) B. M. Trost, J. Xu and T. Schmidt, J. Am. Chem. Soc., 2009, 131, 18343;
37. (b) B. M. Trost, J Xu, J. Am. Chem. Soc., 2005, 127, 2846.
38. (a) Anti-HIV-activity: A. L. Piccinelli, O. Cuesta-Rubio, M. B. Chica, N. Mahmood, B. Pagano, M. Pavone, V. Barone and L. Rastelli, Tetrahedron Lett., 2005, 61, 8206
39. (b) Anti-Epstein-Barr virus: C. Ito, M. Itoigawa, Y. Miyamoto, S. Onoda, K. S. Rao, T. Mukainaka, H. Tokuda, H. Nishino and H. Furukawa, J. Nat. Prod., 2003, 66, 206.
40. For the rationale for the stereoselective course of asymmetric Tsuji-Trost allylation see ESI†.